Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 21

Trial Status

Completed1
Terminated1
Other2

Role Distribution

Principal Investigator1
Other Roles3
PI Rate25%

Activity Timeline

Clinical Trials (4)

NCT02012153Phase 1Terminated
Mesenchymal Stromal Cells in Kidney Transplant Recipients
Kidney Transplant Rejection
StudychairStart date: 2013-12-04
NCT00248040Phase 2Completed
Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation
Ischemia-Reperfusion InjuryKidney Diseases
PrincipalinvestigatorStart date: 2005-10-01
NCT02260375Phase 1Unknown
MSC Therapy in Liver Transplantation
Liver Transplant Rejection
Studychair
NCT02565459Phase 1Unknown
MSC and Kidney Transplant Tolerance (Phase A)
Chronic Renal Failure
Studychair

Research Network

Collaboration Network

13 collaborators·43 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Alessandro Rambaldi, MD

A.O. Ospedale Papa Giovanni XXIII

Moderately Similar
7 trials

Shared therapeutic areas:

Kidney Failure, ChronicKidney Transplant RejectionLiver Transplant Rejection

Worked with same sponsors:

A.O. Ospedale Papa Giovanni XXIIIMario Negri Institute for Pharmacological Research+1 more
Collaborated on 3 trials
Similarity Score42%

Giovanni Rota, MD

A.O. Ospedale Papa Giovanni XXIII

Related
2 trials

Shared therapeutic areas:

Kidney Failure, ChronicKidney Transplant Rejection

Worked with same sponsors:

A.O. Ospedale Papa Giovanni XXIIIMario Negri Institute for Pharmacological Research+1 more
Collaborated on 2 trials
Similarity Score28%

Norberto Perico, MD

Istituto Di Ricerche Farmacologiche Mario Negri

Related
2 trials

Shared therapeutic areas:

Kidney Failure, ChronicKidney Transplant Rejection

Worked with same sponsors:

A.O. Ospedale Papa Giovanni XXIIIMario Negri Institute for Pharmacological Research+1 more
Collaborated on 2 trials
Similarity Score28%

Federica Casiraghi

Istituto Di Ricerche Farmacologiche Mario Negri

Related
2 trials

Shared therapeutic areas:

Kidney Failure, ChronicKidney Transplant Rejection

Worked with same sponsors:

A.O. Ospedale Papa Giovanni XXIIIMario Negri Institute for Pharmacological Research+1 more
Collaborated on 2 trials
Similarity Score28%

Martino Introna, MD

Laboratorio G. Lanzani, Bergamo, Italy

Related
2 trials

Shared therapeutic areas:

Kidney Failure, ChronicKidney Transplant Rejection

Worked with same sponsors:

A.O. Ospedale Papa Giovanni XXIIIMario Negri Institute for Pharmacological Research+1 more
Collaborated on 2 trials
Similarity Score28%

Stefano Fagiuoli, MD

A.O. Ospedale Papa Giovanni XXIII

Related
1 trials

Shared therapeutic areas:

Liver Transplant Rejection

Worked with same sponsors:

Mario Negri Institute for Pharmacological ResearchMonia Lorini
Collaborated on 1 trial
Similarity Score14%

Norberto Perico, MD

IRCCS-Istituto di Ricerche Farmacologiche M. Negri

Related
1 trials

Shared therapeutic areas:

Liver Transplant Rejection

Worked with same sponsors:

Mario Negri Institute for Pharmacological ResearchMonia Lorini
Collaborated on 1 trial
Similarity Score14%

Martino Introna, MD

Laboratorio G.Lanzani, Bergamo, Italy

Related
1 trials

Shared therapeutic areas:

Liver Transplant Rejection

Worked with same sponsors:

Mario Negri Institute for Pharmacological ResearchMonia Lorini
Collaborated on 1 trial
Similarity Score14%

Antonio Pinna, MD

Policlinico S. Orsola Bologna, Italy

Related
1 trials

Shared therapeutic areas:

Liver Transplant Rejection

Worked with same sponsors:

Mario Negri Institute for Pharmacological ResearchMonia Lorini
Collaborated on 1 trial
Similarity Score14%

Michele Colledan, MD

A.O. Ospedale Papa Giovanni XXIII

Related
1 trials

Shared therapeutic areas:

Liver Transplant Rejection

Worked with same sponsors:

Mario Negri Institute for Pharmacological ResearchMonia Lorini
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02012153Phase 1StudyChair

Mesenchymal Stromal Cells in Kidney Transplant Recipients

Kidney Transplant Rejection
Terminated
NCT00248040Phase 2PrincipalInvestigator

Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation

Ischemia-Reperfusion InjuryKidney Diseases
Completed
NCT02260375Phase 1StudyChair

MSC Therapy in Liver Transplantation

Liver Transplant Rejection
Unknown
NCT02565459Phase 1StudyChair

MSC and Kidney Transplant Tolerance (Phase A)

Chronic Renal Failure
Unknown

All 4 trials loaded